All News

Study: High Surgeon Satisfaction Using Patient Decision Aids

by Elizabeth Hofheinz, M.P.H., M.Ed., October 11, 2019 In examining 1,220 pre-visit and 967 post-visit surveys, a team of researchers has found th… Oh no! It looks like you aren’t an OSN Premium Subscriber yet. Click here to sign up or login below. Username or E-mail Password Remember Me     Forgot Password

Cybersecurity: How HSS Gets it Done

By Elizabeth Hofheinz, MPH, MEd., October 11, 2019 Is your hospital “naked,” i.e., is it vulnerable to cyberattacks? Here to help cloak your f… Oh no! It looks like you aren’t an OSN Premium Subscriber yet. Click here to sign up or login below. Username or E-mail Password Remember Me     Forgot Password

Jim Bradley, M.D. Sounds Off: EMRs Violating Sanctity of Physician-Patient Relationship

by Elizabeth Hofheinz, M.P.H., M.Ed., October 10, 2019 Hippocrates probably didn’t have to contend with an EMR. In fact, being old-fashioned, he p… Oh no! It looks like you aren’t an OSN Premium Subscriber yet. Click here to sign up or login below.

Spineway : Approval of Mont-Blanc MIS in Japan

October 14, 2019 Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just obtained approval for its Mont-Blanc MIS line from the Japanese authorities, authorizing it to sell these products for minimally invasive surgeries on this territory. Spineway is now in discussions with several Japanese companies specialized in …

Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs

October 14, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its proprietary hyaluronic acid (“HA”) technology platform to provide treatments across the joint preservation and restoration continuum of care, today announced the appointment of Mira Leiwant to the newly created position of Vice President of Regulatory Affairs, Quality …

Nexxt Spine Celebrates 10 Years of Innovation

October 11, 2019- Noblesville, IN-  Nexxt Spine LLC, a pioneer in the design and manufacturing of leading spinal solutions, is excited to announce a milestone moment in the company’s history.  October 20, 2009 marks the date the first Nexxt Spine recipient underwent surgery under the care of a prominent Nashville surgeon. Fast forward to 2019. …

Centers for Medicare and Medicaid Services Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue Regeneration

Phoenix, AZ (October 11, 2019) Axolotl Biologix, an innovative biotechnology leader in regenerative medicine, announced it has obtained Healthcare Common Procedure Coding System (HCPCS) billing codes from the Centers for Medicare and Medicaid Services (CMS) for all its products effective October 1, 2019. “We’re thrilled that the CMS has made it easier for healthcare providers …

THINK Surgical Receives FDA Clearance to Market Active Robot for Total Knee Replacement Procedures in the United States

FREMONT, Calif., Oct. 9, 2019 /PRNewswire/ — THINK Surgical, Inc. is pleased to announce it has obtained clearance from the U.S. Food and Drug Administration (FDA) to market the TSolution One® Total Knee Application for use in total knee arthroplasty (TKA) in the United States. TSolution One® is a fully active robot which was previously awarded CE Marking and …

Medacta Receives CE Marking for the Lateralized Glenosphere

CASTEL SAN PIETRO, 8 October 2019 – Medacta International has recently obtained CE marking for the lateralized glenosphere. This new implant further expands the Medacta offering for shoulder arthroplasty, which now features a broader range of options for reverse shoulder replacement surgery. The Medacta Shoulder System is a modular solution that includes wide-ranging sizes, adjustable …

Implanet Reports Q3 2019 Revenue of €1.7 Million, Up 12%

October 09, 2019 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces its revenue for the third quarter and first nine months to September 30, 2019. Ludovic Lastennet, CEO of Implanet, commented: “In …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1